x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2018 > 5th ESO Lung Cancer Observatory: innovation and care in the next 12 months
Print

5th ESO Lung Cancer Observatory: innovation and care in the next 12 months

13.04.2018

Geneva, Switzerland

ADVANCED COURSES & SEMINARS

Lung cancer

Description

Chairs: M.S. Aapro, CH - E. Felip, ES


The European School of Oncology is pleased to announce the 5th edition of "ESO Lung Cancer Observatory: innovation and care in the next 12 months", which will be held during the ELCC 2018 European Lung Cancer Conference on April 13 in Geneva, chaired by Dr. M.S Aapro and Dr. E. Felip, ES. The scope of the session is to provide the participants with a take home message on what they can expect to happen in the prostate cancer field in the next 12 months.


The Observatory will be held during the



Faculty

PANELLISTS
M.S. Aapro, Clinique de Genolier, Geneva, CH
C. Adams, Union for International Cancer Control (UICC), Geneva, CH
B. Besse, Institut Gustave Roussy, Paris, FR
H. de Koning, Erasmus University Rotterdam, NL
E. Felip, Vall d’Hebron University Hospital, Barcelona, ES
F. Johansson, Swedish Lung Cancer Association “Stodet”, Stockholm, SE
K. Kerr, Abardeen Royal Infirmary, Foresterhill, Abardeen, UK
F. Mornex, Centre Hospitalier Lyon Sud, FR
P. Van Schil, University Hospital of Antwerp, Edegem, BE

General information

ESO SECRETARIAT
Daniela Mengato
European School of Oncology
Via Turati 29
20121, Milan, Italy
dmengato@eso.net

VENUE
Palexpo
30 Route François-Peyrot
1218 Le Grand-Saconnex
Geneva
Switzerland

ATTENDANCE
Attendance is granted to all participants registered to the ELCC 2018 European Lung Cancer Conference.

Programme

PROGRAMME

13 April 2018
16:45 - 18:15 (Palexpo, Room W)


Early-stage NSCLC, next steps: staging, surgery, molecular determinations
P. Van Schil, BE

Tobacco control, strategies and figures: what’s next?
C. Adams, CH

Lung cancer screening in 2019?
H. de Koning, NL

Radiation oncology: new approaches in 2019
F. Mornex, FR

What to ask your pathologist today and in 2019?
K. Kerr, UK

Developments immunotherapy: what practice changing studies will mature in 2019?
B. Besse, FR

Developments in targeted therapies: what practice changing studies will mature in 2019
E. Felip, ES

The patient’s perspective
F. Johansson, SE

Follow us